HRT Financial’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-58,618
Closed -$389K 3439
2023
Q1
$389K Buy
58,618
+10,345
+21% +$87.4K ﹤0.01% 1560
2022
Q4
$502K Sell
48,273
-127
-0.3% -$1.3K 0.01% 1420
2022
Q3
$493K Sell
48,400
-600
-1% -$6.12K 0.01% 1596
2022
Q2
$497K Hold
49,000
0.01% 1579
2022
Q1
$494K Hold
49,000
﹤0.01% 1791
2021
Q4
$489K Buy
+49,000
New +$489K ﹤0.01% 1900

Other funds holding OCEA

HRT Financial's OCEA Position: Q2 2023 in Review

HRT Financial sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2023, closing a stake of 58,618 shares — an estimated $389K sold.

HRT Financial first reported a position in OCEA in Q4 2021 and held it in 6 quarters. The position peaked at $502K in Q4 2022. 35 funds tracked by Wall St. Rank hold OCEA as of Q2 2023.

  • HRT Financial reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • HRT Financial sold 58,618 Ocean Biomedical, Inc. Common Stock shares in Q2 2023, an estimated $389K.
  • HRT Financial first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • HRT Financial's Ocean Biomedical, Inc. Common Stock position peaked at $502K in Q4 2022.
  • 35 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.